Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy

American Journal of Ophthalmology

Volumn 137, Issue 5, 2004, Pages 826-833

  Lai, Timothy Y Y ^a   Chan, Wai Man ^a,b   Lam, Dennis S C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHORIORETINOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; HUMAN; LATENT PERIOD; LONGITUDINAL STUDY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECORDING; REDUCTION; RETINA MACULA DEGENERATION; STATISTICAL ANALYSIS; SUBRETINAL NEOVASCULARIZATION;

ADULT; AGED; CHOROIDAL NEOVASCULARIZATION; ELECTRORETINOGRAPHY; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; MYOPIA; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; PROSPECTIVE STUDIES; RETINA; RETINAL DISEASES; VISION DISORDERS; VISUAL ACUITY;

EID: 2342541068     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2003.11.079     Document Type: Article

References (28)

1. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials TAP report 1. Arch Ophthalmol. 117:1999;1329-1345
2. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Two-year results of 2 randomized clinical trials TAP report 2. Arch Ophthalmol. 119:2001;198-207
3. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization: verteporfin in photodynamic therapy report 2. Am J Ophthalmol. 131:2001;541-560
4. Verteporfin in Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin 1-year results of a randomized clinical trial. VIP report no. 1. Ophthalmology. 108:2001;841-852
5. Blinder K.J., Blumenkranz M.S., Bressler N.M., et al. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia 2-year results of a randomized clinical trial. VIP report no. 3. Ophthalmology. 110:2003;667-673
6. Spaide R.F., Martin M.L., Slakter J., et al. Treatment of idiopathic subfoveal choroidal neovascular lesions using photodynamic therapy with verteporfin. Am J Ophthalmol. 134:2002;62-68
7. Chan WM, Lam DS, Wong TH, et al. Photodynamic therapy with verteporfin for subfoveal idiopathic choroidal neovascularization: one-year result of an uncontrolled, prospective case series. Ophthalmology 2003;110:2395-2402
8. Yannuzzi L.A., Slakter J.S., Gross N.E., et al. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy a pilot study. Retina. 23:2003;288-298
9. Chan WM, Lam DS, Lai TY, Tam BS, Liu DT, Chan CK. Choroidal vascular remodeling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 2003;87:1453-1458
10. Quaranta M., Mauget-Faysse M., Coscas G. Exudative idiopathic polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin. Am J Ophthalmol. 134:2002;277-280
11. Costa R.A., Farah M.E., Cardillo J.A., Calucci D., Williams G.A. Immediate indocyanine green angiography and optical coherence tomography evaluation after photodynamic therapy for subfoveal choroidal neovascularization. Retina. 23:2003;159-165
12. Michels S., Schmidt-Erfurth U. Sequence of early vascular events after photodynamic therapy. Invest Ophthalmol Vis Sci. 44:2003;2147-2154
13. Miller J.A., Walsh A.W., Kramer M., et al. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol. 113:1995;810-818
14. Husain D., Kramer M., Kenny A.G., et al. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment. Invest Ophthalmol Vis Sci. 40:1999;2322-2331
15. Moshfeghi D.M., Kaiser P.K., Grossniklaus H.E., et al. Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy. Am J Ophthalmol. 135:2003;343-350
16. Flower R.W., von Kerczek C., Zhu L., et al. Theoretical investigation of the role of choriocapillaris blood flow in the treatment of subfoveal choroidal neovascularization associated with age-related macular degeneration. Am J Ophthalmol. 132:2001;85-93
17. Wachtlin J., Behme T., Heimann H., Kellner U., Foerster M.H. Concentric retinal pigment epithelium atrophy after a single photodynamic therapy. Graefes Arch Clin Exp Ophthalmol. 241:2003;518-521
18. Rogers A.H., Martidis A., Greenberg P.B., Puliafito C.A. Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization. Am J Ophthalmol. 134:2002;566-576
19. Sutter E.E., Tran D. The field topography of ERG components in man - I. The photopic luminance response. Vision Res. 32:1992;433-446
20. Keating D., Parks S., Smith D., Evans A. The multifocal ERG unmasked by selective cross-correlation. Vision Res. 42:2002;2959-2968
21. Apostolopoulos M.N., Koutsandrea C.N., Moschos M.N., et al. Evaluation of successful macular hole surgery by optical coherence tomography and multifocal electroretinography. Am J Ophthalmol. 134:2002;667-674
22. Marmor M.F., Tan F. Central serous chorioretinopathy bilateral multifocal electroretinographic abnormalities. Arch Ophthalmol. 117:1999;184-188
23. Palmowski A.M., Allgayer R., Heinemann-Vernaleken B., Ruprecht K.W. Influence of photodynamic therapy in choroidal neovascularization of focal retinal function assessed with the multifocal electroretinogram and perimetry. Ophthalmology. 109:2002;1788-1792
24. Rüther K., Breidenbach K., Schwartz R., Hassenstein A., Richard G. Testing central retinal function with multifocal electroretinography before and after photodynamic therapy. Ophthalmologe. 100:2003;459-464
25. Moschos M.N., Panayotidis D., Moschos M.M., Bouros C., Theodossiadis P.G., Theodossiadis G.P. A preliminary assessment of macular function by MF-ERG in myopic eyes with CNV with complete response to photodynamic therapy. Eur J Ophthalmol. 13:2003;461-467
26. Liang L., Jin C., Wen F., Huang S., Wu D., Wu L. The changes of multifocal electroretinography in the early stage of photodynamic therapy for choroidal neovascularization. Doc Ophthalmol. 107:2003;165-170
27. Marmor M.F., Hood D.C., Keating D., Kondo M., Seeliger M.W., Miyake Y. Guidelines for basic multifocal electroretinography (mfERG). Doc Ophthalmol. 106:2003;105-115
28. Dolan F.M., Parks S., Hammer H. The wide field multifocal electroretinogram reveals retinal dysfunction in early retinitis pigmentosa. Br J Ophthalmol. 86:2002;480-481